US Patent 10294474 Targeting ligands
Patent 10294474 was granted and assigned to Arrowhead Pharmaceuticals, Inc. on May, 2019 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10294474 Targeting ligands
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.